LAS-R TEST PROGRAM— 510(k) K771226

Name: FDA 510(k) clearance K771226
Creator: U.S. Food and Drug Administration
Published: 1977-07-21

Substantially Equivalent

Hyland Therapeutic Div., Travenol Laboratories

FDA 510(k) clearance K771226 for LAS-R TEST PROGRAM, Substantially Equivalent on 1977-07-21. Applicant: Hyland Therapeutic Div., Travenol Laboratories. Device class: 2.

Clearance details

Applicant: Hyland Therapeutic Div., Travenol Laboratories
Product code: Code CFN
Device class: Class 2
Regulation: 21 CFR 866.5510
Advisory panel: Immunology
Date received: 1977-07-01
Decision date: 1977-07-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CFN

view all

K233663 — N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)2023-12-13
K221114 — Immunoglobulin G (IgG)2023-08-02
K192116 — Human IgA liquid reagent kit for Use on SPAPlus2019-09-04
K191985 — Optilite IgA Kit2019-08-19
K191635 — Optilite IgM Kit2019-07-15

More clearances from Hyland Therapeutic Div., Travenol Laboratories

view all

K820835 — ALUMINA SILICA-ACTIVATED PARTIAL THROM1982-04-26
K820192 — HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM1982-03-11
K812220 — NEPHELOMETRIC SOLID TURBIDITY STANDARD1981-08-18
K810078 — Q-PAK THERAPEUTIC DRUG MONIT. CONTROL S1981-02-02
K810077 — OMEGA THERAPEUTIC DRUG MONIT. CONTROL S.1981-01-28

Data sourced from openFDA. This site is unofficial and independent of the FDA.